Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial

By sjmartinez • February 22, 2024

Lu MT, Ribaudo H, Foldyna B, Zanni MV, Mayrhofer T, Karady J, Taron J, Fitch KV, McCallum S, Burdo TH, Paradis K, Hedgire SS, Meyersohn NM, DeFilippi C, Malvestutto CD, Sturniolo A, Diggs M, Siminski S, Bloomfield GS, Alston-Smith B, Desvigne-Nickens P, Overton ET, Currier JS, Aberg JA, Fichtenbaum CJ, Hoffmann U, Douglas PS, Grinspoon SK; REPRIEVE Trial Writing Group. Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial. JAMA Cardiol. 2024 Feb 21. doi: 10.1001/jamacardio.2023.5661. Epub ahead of print. PMID: 38381407.

Tags: Infectious Diseases, Publications

Multiplex pan-filovirus assay performance and reproducibility across varied geographical and resource settings

Smith OA, Merritt S, Kompany JP, Hoff NA, Wong TAS, Kamara V, Tambu M, Halbrook M, Kindrachuk J, Barrall AL, Musene K, Martin SA, Berestecky[...]

Virus reactivation in acute and long COVID-19

Maguire C, Chen J, Rouphael N, Morse BA, Hoch A, Pickering H, Phan HV, Glascock A, Chu V, Dandekar R; IMPACC Network; Corry D, Kheradmand[...]

Variation in Hospital Visiting Hour Policies in Acute Care Facilities in Four U.S. States: An Exploratory Cross-Sectional Analysis

Garcia CY, Chou C, Caso E, Hudspeth JC, Allan-Blitz LT. Variation in Hospital Visiting Hour Policies in Acute Care Facilities in Four U.S. States: An[...]